L’Oréal Groupe has taken skin-care innovation to new heights by unveiling the new L’Oréal Cell BioPrint at the 2025 Consumer Electronics Show (CES) in Las Vegas. The compact, “lab-on-a-chip” device promises to take personalized skin care to the next level by offering in-depth insights into a user’s skin biology in just five minutes.
Tapping into something called proteomics, the study of proteins and how they affect skin aging, the Cell BioPrint can analyze key biomarkers to reveal our skin’s biological age, predict how it will respond to ingredients like retinol and even forecast potential concerns like dark spots and enlarged pores. The goal? To shift from reactive to proactive skin care, allowing users to address issues before they surface.
Here’s how it works: a facial tape strip collects proteins from the skin, which are analyzed by the device to deliver personalized results. In addition to assessing skin’s biological age (and how your skin is aging), users can learn how effective specific skin-care ingredients will work for them, cutting down on the guesswork of finding the right products.
“Cell BioPrint combines cutting-edge microfluidic technology with our century-long expertise in skin science,” said Barbara Lavernos, deputy CEO of research, innovation and technology at L’Oréal Groupe, in a press release. “This device allows people to discover deeper insights about their skin and take proactive steps to preserve its beauty and longevity.”
Developed in partnership with Korean startup NanoEnTek, the device addresses the growing demand for hyper-personalization. According to L’Oréal, nearly 80 percent of U.S. skin-care users still rely on trial and error to find products that work, often cycling through multiple options before landing on a favorite.
The Cell BioPrint is expected to debut in Asia with a L’Oréal brand later this year. Stay tuned—our skin-care routines may never be the same again.
